Rasgos diferenciales de la patología cardiovascular en el ancianoinsuficiencia cardíaca, cardiopatía isquémica y fibrilación auricular

  1. Ayala, R.
  2. Jaramillo, J.
  3. Ramos, M.
  4. Cachuan, S.
  5. Garmendia, B.
  6. Quezada, M.
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2018

Serie: 12

Número: 62

Páginas: 3659-3669

Tipo: Artículo

DOI: HTTPS://DOI.ORG/10.1016/J.MED.2018.09.004 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumen

Resumen La prevalencia de enfermedades cardiovasculares aumenta con la edad. Los cambios cardiovasculares propios del envejecimiento y la frecuencia de enfermedades que evolucionan a ellas en este grupo etario explican esta asociación. Es en ese segmento de la población donde resulta más complejo el manejo de los pacientes, debido a dificultades en el diagnóstico, restricción en procedimientos invasivos, escasa representación en ensayos clínicos y mala tolerancia a los tratamientos debido a la alta comorbilidad y a las interacciones en el contexto de polifarmacia. The prevalence of cardiovascular disease increases with age. Age-related cardiovascular changes and the frequency of conditions that progress to these diseases in this age group explain this association. Patients in this segment of the population are more difficult to manage due to diagnostic difficulties and restrictions for invasive procedures. These patients are underrepresented in clinical trials and have poor tolerance to treatment because of their many comorbidities and interactions in the context of polypharmacy.

Referencias bibliográficas

  • Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M. Heart disease and stroke statistics 2016 Update: a report from the American Heart Association. Circulation. 2016;133(4):e38-360.
  • Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003;108:977-82.
  • McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441-6.
  • Panjrath G, Ahmed A. Diagnosis and management of heart failure in older adults. Heart Failure Clin. 2017;13:427-44.
  • Ahmed A. Chronic heart failure in older adults. Med Clin N Am. 2011;95:439-61.
  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016; 128:1-85.
  • Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH. 2013 ACCF/AHA Guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-239.
  • Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;3:215-25.
  • Doukky R, Avery E, Mangla A, Collado FM, Ibrahim Z, Poulin MF. Impact of dietary sodium restriction on heart failure outcomes. JCHF Heart Fail. 2016;4:24-35.
  • Bonilla-Palomas JL, Gámez-López AL, Castillo-Domínguez JC, Moreno-Conde M, López Ibáñez MC, Alhambra Expósito R. Nutritional intervention in malnourished hospitalized patients with heart failure. Arch Med Research. 2016;47:535-40.
  • O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439-50.
  • Vidán T, Sánchez E, Fernández-Avilés F, Serra-Rexach JA. FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics. Clin Cardiol. 2014;37:725-32.
  • Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;6:996-1004.
  • Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014;129:837-47.
  • Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042-6.
  • Gómez-Doblas JJ, Muñiz J, Alonso Martín J, Rodríguez-Roca G, Lobos JM, Awamleh P. Prevalencia de fibrilación auricular en España. Resultados del estudio OFRECE. Rev Esp Cardiol. 2014;67:259-69.
  • Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386:154-62.
  • Allessie MA, de Groot NM, Houben RP, Schotten U, Boersma E, Smeets JL. Electropathological substrate of long standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol. 2010;3:606-15.
  • Lim HS, Willoughby SR, Schultz C, Gan C, Alasady M, Lau DH. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol. 2013;61:852-60.
  • Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-962.
  • Bo M, Grisoglio E, Brunetti E, Falcone Y, Marchionni N. Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence. Eur J Inter Med. 2017;41:18-27.
  • Hernández M, Suárez C. Avances en el tratamiento anticoagulante de la fibrilación auricular. Med Clin. 2015;145(3):124-30.
  • Suárez C, Camafort M, Cepeda JM, Díez-Manglano J, Formiga F, Pose A. Tratamiento antitrombótico en el paciente anciano con fibrilación auricular. Rev Clin Esp. 2015;3:171-81.
  • Parks AL, Fang MC. Anticoagulation in older adults with multimorbidity. Clin Geriatr Med. 2016;32:341-6.
  • Veiga F, Malfeito MR, Barros SM, Magariños MM. La anticoagulación oral en el anciano con fibrilación auricular no valvular. Rev Esp Geriatr Gerontol. 2015:50(3):134-42.
  • Cosin-Sales J, Olalla J. Tratamiento farmacológico de la fibrilación auricular. Antiarritmicos y anticoagulantes orales. Rev Esp Cardiol Supl. 2016;16(A):33-9.
  • EUGenMed Cardiovascular Clinical Study Group, Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37(1):24-34.
  • Kurotobi T, Sato H, Kinjo K, Nakatani D, Mizuno H, Shimizu M. Reduced colateral circulation to the infarct related artery in elderly patients with acute myocardial infarction. J Am Coll Cardiol. 2004;44(1):28-34.
  • Salech F, Jara R, Michea L. Cambios fisiológicos asociados al envejecimiento. Physicological changes associated with normal aging. Rev Med Clin. 2012;23(1):19-29.
  • Smith JG, Wieloch M, Koul S, Braun OÖ, Lumsden J, Rydell E. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HASBLED score. EuroIntervention. 2012;8:672-8.
  • Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby L. Baseline risk of major bleeding in non ST-segment elevation myocardial infarction: the CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines) bleeding score. Circulation. 2009;119:1873-82
  • Lopes RD, Alexander KP, Manoukian SV, Bertrand ME, Feit F, White HD. Advanced age, antithrombotic strategy, and bleeding in non ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2009;53(12):1021-30.
  • Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, An-dreotti F. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016;37:267-315.
  • Ibañez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018:119-77.
  • McCune C, McKavanagh P, Menown IB. A review of current diagnosis, investigation, and management of acute coronary syndro-mes in elderly patients. Cardiol Ther. 2015;4(2):95-116.
  • Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31(18):2197-204.
  • Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J. 2017;0:1-48.
  • Engberding N, Wenger NK. Acute coronary syndromes in the elderly. F1000Res. 2017;6:1791.
  • Mischie A, Andrei C, Sinescu C, Bajraktari GN, Ivan E, Chatziathanasiou G. Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary síndrome. J Geriatr Cardiol. 2017;14:442-56.
Fuente de los datos: Dialnet